DK240889A - S-ENANTIOMERIC GLUTARAMIDE DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS - Google Patents

S-ENANTIOMERIC GLUTARAMIDE DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS Download PDF

Info

Publication number
DK240889A
DK240889A DK240889A DK240889A DK240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A DK 240889 A DK240889 A DK 240889A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
enantiomeric
compounds
preparations containing
pharmaceutical preparations
Prior art date
Application number
DK240889A
Other languages
Danish (da)
Other versions
DK240889D0 (en
DK172032B1 (en
Inventor
John Christopher Danilewics
Michael Trevelyan Williams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK240889D0 publication Critical patent/DK240889D0/en
Publication of DK240889A publication Critical patent/DK240889A/en
Application granted granted Critical
Publication of DK172032B1 publication Critical patent/DK172032B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Detergent Compositions (AREA)

Abstract

S Enantiomeric diuretic agent of the formula: <CHEM> wherein each R and R<4> is H or one of R and R<4> is H and the other is a biolabile ester group, a process for their preparation and intermediates therefor.
DK240889A 1988-05-19 1989-05-18 (S) -enantiomeric glutaramide derivatives and these compounds for use as pharmaceuticals and pharmaceutical preparations containing these compounds and (S) -enantiomeric glutaric acid derivatives useful as intermediates in the preparation of these compounds DK172032B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8811873 1988-05-19
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (3)

Publication Number Publication Date
DK240889D0 DK240889D0 (en) 1989-05-18
DK240889A true DK240889A (en) 1989-11-20
DK172032B1 DK172032B1 (en) 1997-09-22

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
DK240889A DK172032B1 (en) 1988-05-19 1989-05-18 (S) -enantiomeric glutaramide derivatives and these compounds for use as pharmaceuticals and pharmaceutical preparations containing these compounds and (S) -enantiomeric glutaric acid derivatives useful as intermediates in the preparation of these compounds

Country Status (29)

Country Link
EP (1) EP0342850B1 (en)
JP (1) JPH072699B2 (en)
KR (1) KR920000561B1 (en)
CN (1) CN1015361B (en)
AT (1) ATE76399T1 (en)
AU (1) AU602813B2 (en)
CA (1) CA1331197C (en)
CS (1) CS274502B2 (en)
DD (1) DD283772A5 (en)
DE (1) DE68901582D1 (en)
DK (1) DK172032B1 (en)
EG (1) EG19007A (en)
ES (1) ES2037418T3 (en)
FI (1) FI93541C (en)
GB (1) GB8811873D0 (en)
GR (1) GR3004968T3 (en)
HU (1) HU205067B (en)
IE (1) IE60724B1 (en)
IL (1) IL90267A (en)
MX (1) MX16067A (en)
MY (1) MY104735A (en)
NO (1) NO173647C (en)
NZ (1) NZ229186A (en)
PH (1) PH26740A (en)
PL (1) PL154813B1 (en)
PT (1) PT90584B (en)
SU (1) SU1766251A3 (en)
YU (1) YU47973B (en)
ZA (1) ZA893696B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DK0644176T3 (en) * 1993-09-22 1996-02-26 Pfizer Ltd Hydrogenation
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (en) 2005-11-09 2007-12-26 Novartis Ag DOUBLE ACTION COMPOUNDS OF ANGIOTENSIN RECEPTOR BLOCKERS AND NEUTRAL ENDOPEPTIDASE INHIBITORS
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
PL2887961T3 (en) 2012-08-24 2021-11-08 Novartis Ag Nep inhibitors for treating diseases characterized by atrial enlargement or remodeling
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
WO2017072636A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (en) * 1986-12-11 1988-08-27 알렌 제이.스피겔 Spiro-Substituted Glutaramide Diuretics

Also Published As

Publication number Publication date
CS296589A2 (en) 1990-09-12
GB8811873D0 (en) 1988-06-22
FI93541C (en) 1995-04-25
YU47973B (en) 1996-08-13
KR920000561B1 (en) 1992-01-16
PL154813B1 (en) 1991-09-30
DD283772A5 (en) 1990-10-24
IL90267A0 (en) 1989-12-15
EG19007A (en) 1994-11-30
JPH072699B2 (en) 1995-01-18
FI93541B (en) 1995-01-13
MX16067A (en) 1993-10-01
EP0342850A1 (en) 1989-11-23
NO173647C (en) 1994-01-12
ES2037418T3 (en) 1993-06-16
ZA893696B (en) 1990-12-28
PT90584B (en) 1994-09-30
CA1331197C (en) 1994-08-02
PL279491A1 (en) 1989-11-27
CN1015361B (en) 1992-02-05
IL90267A (en) 1993-08-18
GR3004968T3 (en) 1993-04-28
NO892002D0 (en) 1989-05-18
CS274502B2 (en) 1991-04-11
MY104735A (en) 1994-05-31
HUT53596A (en) 1990-11-28
SU1766251A3 (en) 1992-09-30
JPH0222256A (en) 1990-01-25
HU205067B (en) 1992-03-30
DK240889D0 (en) 1989-05-18
FI892386A (en) 1989-11-20
NZ229186A (en) 1990-10-26
PT90584A (en) 1989-11-30
AU3490489A (en) 1989-11-23
FI892386A0 (en) 1989-05-18
PH26740A (en) 1992-09-28
EP0342850B1 (en) 1992-05-20
DE68901582D1 (en) 1992-06-25
IE60724B1 (en) 1994-08-10
KR900017993A (en) 1990-12-20
CN1037704A (en) 1989-12-06
NO173647B (en) 1993-10-04
ATE76399T1 (en) 1992-06-15
IE891613L (en) 1989-11-19
DK172032B1 (en) 1997-09-22
YU102289A (en) 1991-06-30
AU602813B2 (en) 1990-10-25
NO892002L (en) 1989-11-20

Similar Documents

Publication Publication Date Title
DK590787A (en) CEPHALOSPORIN SULPHONES, PROCEDURES AND INTERMEDIATES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH A CONNECTION
NO894417D0 (en) BU-3608 FA-1 AND FA-2, PROCEDURES FOR PREPARING THEREOF, ALCOHOLIC DERIVATIVES THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING BU-3608 FA-1, FA-2 OR ALCOHOLIC DERIVATIVES THEREOF.
DK240889A (en) S-ENANTIOMERIC GLUTARAMIDE DERIVATIVES AND THEIR USE AS PHARMACEUTICAL AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS
AU6700286A (en) Use of antidotal amides for herbicidal compositions of sulphonic urea derivatives
PT91203A (en) PROCESS FOR THE PREPARATION OF NEW DERIVATIVES OF BU-3608 ANTIBIOTICS AND OF PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DE3688087T2 (en) CEPHEMIC COMPOUNDS, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME.
NO884005L (en) FLUORATED DERIVATIVES OF AMINO ACIDS SPECIAL FOR USE AS A SURFACTIVE AGENT.
ES2045067T3 (en) PROCEDURE FOR PREPARING NEW TIAZOL COMPOUNDS.
DK0571243T3 (en) Thiochromane derivatives, processes for their preparation, and pharmaceutical agents containing ice
ATE118215T1 (en) CEPHALOSPORINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS AND INTERMEDIATE COMPOUNDS.
FI890678A0 (en) Analogous process for the preparation of therapeutically useful 1,3-dioxane alkenic acid derivatives
WO1987004435A3 (en) Xanthine compounds
DK424888D0 (en) NAPHTHOTHIAZEPINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES
AU3620089A (en) New process for the preparation of n-(23-vinblastinoyl) derivatives of 1-amino-methyl-phosphonic acid
ES2039270T3 (en) GAMMA-L-GLUTAMIL-4-NITROANILIDE DERIVATIVES AND PROCEDURE FOR DETERMINING GAMMA-GTP ACTIVITY USING THEM.
FI921238A0 (en) N&#39;-alkoxy or N&#39;-aralkyloxy-N6-cyanogriseolinic acid derivatives useful as intermediates

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK